XML 18 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Share-based Compensation
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
(
5
)
Share-Based Compensation
 
Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).
 
The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended
December 31, 2018.
The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):
 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
Share-based compensation related to:   2019   2018   2019   2018
Common stock grants   $
100
    $
100
    $
300
    $
405
 
Stock option grants    
60
     
9
     
91
     
143
 
Restricted Stock Unit Awards ("RSUs")    
313
     
163
     
778
     
415
 
Total share-based compensation   $
473
    $
272
    $
1,169
    $
963
 
 
The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately
$176
thousand and
$289
thousand for the
three
-month periods ended
September 30, 2019
and
2018,
respectively, and approximately
$524
thousand and
$649
thousand for the
nine
-month periods ended
September 
30,
2019
and
2018,
respectively.
 
The following is a summary of stock option activity under all plans for the
nine
-month period ended
September 
30,
2019:
 
    Shares Under Options   Weighted Average Exercise Price
(per share)
  Weighted Average Remaining Contractual Life
(in years)
  Aggregate Intrinsic Value
(in thousands)
Outstanding at December 31, 2018    
134,043
    $
20.46
     
 
     
 
 
Granted    
16,536
     
38.61
     
 
     
 
 
Exercised    
(39,965
)    
14.06
     
 
     
 
 
Outstanding at September 30, 2019    
110,614
    $
25.49
     
5.83
    $
1,450
 
Exercisable at September 30, 2019    
86,578
    $
22.71
     
5.32
    $
1,376
 
Vested and expected to vest at September 30, 2019    
110,614
    $
25.49
     
5.83
    $
1,450
 
 
On
June 5, 2019,
the Company granted options to its directors for the purchase of
16,536
shares of common stock at that day’s closing price of
$38.61.
The compensation expense related to these grants was determined as the fair value of the options using the Black-Scholes option pricing model based on the following assumptions:
 
Expected volatility    
28.9
%
Expected dividends    
None
 
Risk-free interest rate    
2.3
%
Exercise price   $
38.61
 
Expected term (years)    
6.0
 
Weighted-average grant date fair value   $
12.70
 
 
The stock volatility for each grant is determined based on a review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term, and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected term is estimated based on historical option exercise activity.
 
During the
nine
-month periods ended
September 30, 2019
and
2018,
the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately
$867
thousand and
$1.2
million, respectively, and the total amount of consideration received by the Company from the exercised options was approximately
$562
thousand and
$1.3
million, respectively. At its discretion, the Company allows option holders to surrender previously-owned common stock in lieu of paying the exercise price and withholding taxes.
No
shares were surrendered for this purpose for the periods ended
September 30, 2019
and
2018.
 
On
February 19, 2019,
the Company’s Compensation Committee approved
the award of
$400
thousand, payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the
2003
Incentive Plan, subject to his continued employment and the terms of his employment agreement. The shares will be issued in
December 2019.
 
The following table summarizes information about RSU activity during the
nine
-month period ended
September
 
30,
2019:
 
   
Restricted
Stock Units
  Weighted Average
Award Date
Fair Value
Outstanding at December 31, 2018    
72,176
    $
23.60
 
Awarded    
67,540
     
33.53
 
Shares vested    
(19,860
)    
23.53
 
Outstanding at September 30, 2019    
119,856
    $
28.25
 
 
At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax and the remaining amount is converted into the equivalent number of common shares. During the
nine
-month periods ended
September 30, 2019
and
2018,
8,132
and
5,238
shares were surrendered at an average market price of
$33.35
and
$27.60,
respectively.
 
As of
September 30, 2019,
the Company had approximately
$2.8
million of unrecognized compensation expense that is expected to be recognized over a period of
3.5
years.